Full Library
An Unexpectedly High Incidence of Invasive Fungal Diseases in Solid Organ Transplant Recipients Taking Belatacept for Organ Rejection Prophylaxis: A Single-Center Retrospective Cohort Study
Resource type
Journal Article
Authors/contributors
- Bell, Elizabeth (Author)
- Pisano, Jennifer (Author)
- Brown, Manasa (Author)
- Friedman, Daniel (Author)
Title
An Unexpectedly High Incidence of Invasive Fungal Diseases in Solid Organ Transplant Recipients Taking Belatacept for Organ Rejection Prophylaxis: A Single-Center Retrospective Cohort Study
Abstract
Among solid organ transplant recipients taking belatacept, 15% developed invasive fungal diseases. The most common invasive fungal diseases were aspergillosis (56%) and candidiasis (22%). The infected cohort was more likely to receive basiliximab, undergo lung transplantation, or identify as White. Higher rates of aspergillosis were seen in this lung cohort than previously reported.
Publication
Open Forum Infectious Diseases
Date
2024-06-01
Volume
11
Issue
6
Pages
ofae158
Journal Abbr
Open Forum Infectious Diseases
Accessed
9/5/24, 7:44 PM
ISSN
2328-8957
Short Title
An Unexpectedly High Incidence of Invasive Fungal Diseases in Solid Organ Transplant Recipients Taking Belatacept for Organ Rejection Prophylaxis
Library Catalog
Silverchair
Citation
Bell, E., Pisano, J., Brown, M., & Friedman, D. (2024). An Unexpectedly High Incidence of Invasive Fungal Diseases in Solid Organ Transplant Recipients Taking Belatacept for Organ Rejection Prophylaxis: A Single-Center Retrospective Cohort Study. Open Forum Infectious Diseases, 11(6), ofae158. https://doi.org/10.1093/ofid/ofae158
ORGANISMS
SOLID ORGANS AND MCSS
Link to this record